Article Correctness Is Author's Responsibility: Novel Compounds Designed To Inhibit SARS-CoV-2 Main Protease

The article below may contain offensive and/or incorrect content.

This shows the mpro inhibitorResearchers have developed two new compounds that are able to inhibit SARS-CoV-2 main protease. The study reports one of the compounds is a strong drug candidate for further investigative trials in the treatment of coronavirus.